A Phase 1 Randomized, Open-Label, 2-Sequence, 2-Period Crossover Study Of The Effect Of Multiple Doses Of PD-0332991 On Midazolam Pharmacokinetics In Healthy Women of Non-Childbearing Potential
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2014
At a glance
- Drugs Palbociclib (Primary) ; Midazolam
- Indications Cancer; Epilepsy; Sleep disorders
- Focus Pharmacokinetics
- Sponsors Pfizer
- 09 Apr 2014 Results presented at the 105th Annual Meeting of the American Association for Cancer Research.
- 13 Aug 2013 Actual end date changed from Jun 2013 to Jul 2013, as reported by ClinicalTrials.gov.
- 30 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.